S

Surgical Science Sweden AB
STO:SUS

Watchlist Manager
Surgical Science Sweden AB
STO:SUS
Watchlist
Price: 129.4 SEK 0.7%
Market Cap: 6.6B SEK
Have any thoughts about
Surgical Science Sweden AB?
Write Note

Surgical Science Sweden AB
Total Liabilities & Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Surgical Science Sweden AB
Total Liabilities & Equity Peer Comparison

Comparables:
EKTA B
CEVI
GETI B
ARJO B
S
STIL

Competitive Total Liabilities & Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities & Equity CAGR 3Y CAGR 5Y CAGR 10Y
S
Surgical Science Sweden AB
STO:SUS
Total Liabilities & Equity
kr5B
CAGR 3-Years
73%
CAGR 5-Years
119%
CAGR 10-Years
N/A
Elekta AB (publ)
STO:EKTA B
Total Liabilities & Equity
kr31.4B
CAGR 3-Years
8%
CAGR 5-Years
5%
CAGR 10-Years
N/A
CellaVision AB
STO:CEVI
Total Liabilities & Equity
kr957.3m
CAGR 3-Years
10%
CAGR 5-Years
18%
CAGR 10-Years
19%
Getinge AB
STO:GETI B
Total Liabilities & Equity
kr53.6B
CAGR 3-Years
6%
CAGR 5-Years
4%
CAGR 10-Years
N/A
Arjo AB (publ)
STO:ARJO B
Total Liabilities & Equity
kr15.4B
CAGR 3-Years
4%
CAGR 5-Years
3%
CAGR 10-Years
N/A
S
Stille AB
STO:STIL
Total Liabilities & Equity
kr1B
CAGR 3-Years
82%
CAGR 5-Years
53%
CAGR 10-Years
33%

See Also

What is Surgical Science Sweden AB's Total Liabilities & Equity?
Total Liabilities & Equity
5B SEK

Based on the financial report for Jun 30, 2024, Surgical Science Sweden AB's Total Liabilities & Equity amounts to 5B SEK.

What is Surgical Science Sweden AB's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 5Y
119%

Over the last year, the Total Liabilities & Equity growth was 1%. The average annual Total Liabilities & Equity growth rates for Surgical Science Sweden AB have been 73% over the past three years , 119% over the past five years .

Back to Top